Earnings summaries and quarterly performance for FLOWSERVE.
Executive leadership at FLOWSERVE.
Scott Rowe
Detailed
Chief Executive Officer
CEO
AD
Alice DeBiasio
Detailed
President, Flow Control Division
AS
Amy Schwetz
Detailed
Chief Financial Officer
BB
Brian Boukalik
Detailed
Chief Human Resources Officer
LD
Lamar Duhon
Detailed
President, Flowserve Pumps Division
SV
Scott Vopni
Detailed
Chief Accounting Officer
SH
Susan Hudson
Detailed
Chief Legal Officer and Corporate Secretary
Board of directors at FLOWSERVE.
Research analysts who have asked questions during FLOWSERVE earnings calls.
Deane Dray
RBC Capital Markets
8 questions for FLS
Also covers: AME, ATKR, CARR +21 more
JG
Joseph Giordano
TD Cowen
8 questions for FLS
Also covers: ABLZF, AME, APH +21 more
DK
Damian Karas
UBS
6 questions for FLS
Also covers: ALH, AOS, CGNX +14 more
MH
Michael Halloran
Baird
6 questions for FLS
Also covers: AOS, CXT, DOV +19 more
NJ
Nathan Jones
Stifel, Nicolaus & Company, Incorporated
6 questions for FLS
Also covers: AOS, BMI, CR +20 more
Andrew Kaplowitz
Citigroup
5 questions for FLS
Also covers: ACM, AOS, APG +29 more
AO
Andrew Obin
Bank of America
4 questions for FLS
Also covers: ALH, ALLE, AME +17 more
SB
Saree Boroditsky
Jefferies
4 questions for FLS
Also covers: AOS, APH, CSL +15 more
BL
Brett Linzey
Mizuho Securities
3 questions for FLS
Also covers: AIRO, AIT, ALLE +15 more
Andy Kaplowitz
Citigroup Inc.
2 questions for FLS
Also covers: ACM, APG, ATKR +14 more
MH
Mike Halloran
Robert W. Baird & Co. Incorporated
2 questions for FLS
Also covers: ALH, AOS, CXT +12 more
Nathan Jones
Stifel
2 questions for FLS
Also covers: ADNT, AOS, BMI +8 more
EL
Eric Look
Mizuho Financial Group, Inc.
1 question for FLS
Joseph Ritchie
Goldman Sachs
1 question for FLS
Also covers: ALLE, CARR, CGNX +22 more
Recent press releases and 8-K filings for FLS.
Flowserve Reports Strong Q4 and Full Year 2025 Results, Issues 2026 Guidance, and Announces Acquisition
FLS
Earnings
Guidance Update
M&A
- Flowserve reported $506 million in operating cash flow for full year 2025, a 19% increase versus 2024, and achieved 300 basis points of expansion in adjusted operating margins, reaching its 2027 margin targets two years ahead of schedule. The company also delivered 38% adjusted EPS growth in 2025.
- For 2026, Flowserve expects total reported sales growth of 5%-7% (with 1%-3% organic sales growth), approximately 100 basis points of adjusted operating margin expansion, and adjusted earnings per share of $4-$4.20, representing a 13% midpoint increase over 2025. Bookings are projected to grow mid-single digits.
- The company signed a definitive agreement to acquire the valve and actuation business from Trillium Flow Technologies, aiming to strengthen its valve and actuation portfolio and expand its global reach in attractive end-markets like nuclear. Flowserve also established new 2030 long-term financial targets, including a mid-single digit organic sales CAGR and 20% adjusted operating margins by 2030, alongside a double-digit adjusted EPS CAGR from 2025.
7 hours ago
Flowserve Reports Strong Q4 2025 Results and Provides Positive 2026 Outlook
FLS
Earnings
Guidance Update
M&A
- Flowserve reported strong Q4 2025 results, with total revenues growing 4% year-over-year to $1.2 billion and adjusted EPS increasing 59% to $1.11. The adjusted operating margin expanded 420 basis points to 16.8%, surpassing the 2027 long-term target.
- For 2026, the company anticipates total reported sales growth of 5%-7% and adjusted EPS between $4.00-$4.20, representing a 13% midpoint increase from 2025. Adjusted operating margin is expected to expand by approximately 100 basis points.
- Flowserve has signed a definitive agreement to acquire the Trillium Valves business, which is expected to contribute to reported sales growth and strengthen its position in the nuclear and traditional power markets. Organic bookings are projected to grow mid-single digits in 2026, driven by aftermarket momentum and growth in the power and general industries markets.
8 hours ago
Flowserve Reports Strong Q4 and Full-Year 2025 Results, Announces Trillium Acquisition, and Sets 2030 Targets
FLS
Earnings
Guidance Update
M&A
- Flowserve delivered outstanding financial performance in 2025, achieving its long-term margin targets two years ahead of plan, with 300 basis points of adjusted operating margin expansion and 38% adjusted EPS growth. The company also returned $365 million to shareholders through dividends and share repurchases.
- For Q4 2025, bookings were $1.2 billion, a 3% increase versus the prior year period, driven by 10% growth in aftermarket bookings to $682 million. Additionally, Flowserve signed a definitive agreement to acquire the valve and actuation business from Trillium Flow Technologies.
- For 2026, Flowserve expects total reported sales growth of 5%-7% and adjusted EPS of $4-$4.20, representing a 13% midpoint increase over 2025, with approximately 100 basis points of adjusted operating margin expansion.
- The company established new 2030 long-term financial targets, aiming for a mid-single digit organic sales CAGR, 20% adjusted operating margins, and a double-digit adjusted EPS CAGR from 2025.
8 hours ago
Flowserve (FLS) Announces Q4 2025 Guidance and FY 2024/2025 Results
FLS
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Flowserve provided Q4 2025 guidance with Adjusted EPS of $2.25 - $2.35, Adjusted Revenue Growth of 4% - 6%, Adjusted Operating Margin Expansion of +100 - +150 bps, and Free Cash Flow Conversion of ~100%. This guidance is based on key assumptions including bookings growth of 4% - 6% and continued strong aftermarket demand.
- For the full year 2024, Flowserve reported Adjusted Diluted EPS of $2.63.
- In FY 2025, the Flowserve Pumps Division achieved Adjusted Operating Income of $636,589 thousand, and the Flow Control Division reported Adjusted Operating Income of $228,747 thousand.
- For Q4 2025, the Flowserve Pumps Division's Adjusted Operating Income was $174,754 thousand, and the Flow Control Division's Adjusted Operating Income was $77,240 thousand.
- The FY 2025 bookings mix for the Pumps Division was 69% Aftermarket (AM) and 31% Original Equipment (OE), while the Flow Control Division's mix was 27% AM and 73% OE.
1 day ago
Flowserve Reports Q4 and Full Year 2025 Results and Announces Strategic Acquisition
FLS
Earnings
Guidance Update
M&A
- Flowserve reported strong Q4 2025 adjusted operating margin of 16.8% and adjusted EPS of $1.11, contributing to full-year 2025 adjusted EPS of $3.64 and $506 million in cash from operations.
- The company initiated full-year 2026 guidance, forecasting total sales growth of 5% to 7% and adjusted EPS between $4.00 and $4.20.
- Flowserve signed a definitive agreement to acquire Trillium Flow Technologies’ Valves Division (TVD) for $490 million in cash, a transaction expected to close mid-year 2026 and be accretive to adjusted operating income in 2026. TVD had annualized revenues of approximately $200 million in 2025.
- The company also established 2030 financial targets, aiming for a mid-single digit organic sales CAGR, approximately 20% adjusted operating margin, and double-digit adjusted EPS CAGR.
1 day ago
Flowserve Reports Strong Q4 and Full Year 2025 Results, Initiates 2026 Guidance, and Announces Acquisition
FLS
Earnings
Guidance Update
M&A
- Flowserve Corporation reported strong fourth quarter 2025 adjusted EPS of $1.11 and full year 2025 adjusted EPS of $3.64, with full year bookings reaching $4.7 billion and cash from operations at $506 million.
- The company initiated full year 2026 guidance, forecasting total sales growth of 5% to 7% and adjusted EPS of $4.00 to $4.20.
- Flowserve announced a definitive agreement to acquire Trillium Flow Technologies’ Valves Division.
- New 2030 financial targets were established, including a mid-single digit organic sales CAGR, approximately 20% adjusted operating margin, and double-digit adjusted EPS CAGR.
1 day ago
Flowserve to Acquire Trillium Flow Technologies’ Valves Division
FLS
M&A
New Projects/Investments
Guidance Update
- Flowserve Corporation has signed a definitive agreement to acquire Trillium Flow Technologies’ Valves Division (TVD) for $490 million in cash.
- The transaction is expected to close mid-year 2026 and is anticipated to be accretive to adjusted operating income in 2026, excluding anticipated synergies.
- TVD is projected to have annualized revenues of approximately $200 million with adjusted EBITDA margins in the high teens, and the purchase price represents approximately 12.3x TVD’s 2025 adjusted EBITDA.
- This acquisition is intended to accelerate Flowserve's power end-market growth strategy, strengthen its valve and actuation product portfolio, and enhance service capabilities, particularly in nuclear and traditional power generation.
1 day ago
Solstice Gold Defines Extension of IP Anomaly at Red Cedar Discovery
FLS
New Projects/Investments
- Solstice Gold Corp. has identified a significant eastern extension of the chargeability anomaly at its Red Cedar Discovery within the Strathy Gold Project, following an additional 17.2 line-km Alpha IP survey conducted in late 2025.
- The combined 2024 and 2025 IP surveys now define a large, continuous chargeability anomaly measuring at least 1,000 m x 600 m, which remains open to the east and contains the Red Cedar Discovery hole with an intercept of 8.52 g/t Au over 3.5m.
- A 2,750m diamond drill program is scheduled to commence by mid-February to further explore this extensive anomaly.
3 days ago
Solstice Gold Expands Strathy Gold Project Land Position
FLS
New Projects/Investments
M&A
Executive Compensation
- Solstice Gold Corp. has entered into agreements to acquire 47.2 hectares of claims adjacent to its Red Cedar Discovery at the Strathy Gold Project in Ontario, expanding its total land package to approximately 46 km².
- These acquisitions are strategically important as the Red Cedar chargeability anomaly, which hosts a high-grade gold discovery (8.5 g/t Au over 3.5 m), extends onto the newly acquired claims.
- The company is finalizing drill targets for a fully funded ~2,750 m drill program planned for Q1 2026, with drilling scheduled to commence in the next few weeks.
- The acquisitions involve a cash payment of $40,000 and the issuance of 372,692 common shares, along with a 1.5% net smelter return royalty for one unpatented claim, all subject to TSX Venture Exchange approval.
Jan 26, 2026, 12:00 PM
AirNexis Therapeutics Launches with $200M Series A and In-licenses COPD Drug
FLS
New Projects/Investments
M&A
- AirNexis Therapeutics launched with a $200 million Series A financing round led by Frazier Life Sciences, with participation from OrbiMed, SR One, Life Sciences at Goldman Sachs Alternatives, Longitude Capital, and Enavate Sciences.
- The company in-licensed AN01, a dual PDE3/4 inhibitor in Phase 2 development for Chronic Obstructive Pulmonary Disease (COPD), from Haisco Pharmaceutical Group.
- Under the agreement, Haisco Pharmaceutical Group received a 19.9% equity stake in AirNexis, an upfront payment of $40 million, and is eligible for up to $955 million in regulatory and commercial milestones plus low double-digit royalties on net sales.
- The proceeds from the Series A financing will fund the global clinical development of AN01.
Jan 9, 2026, 1:00 PM
Quarterly earnings call transcripts for FLOWSERVE.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more